Dudley Robert Michael 4
4 · Transcode Therapeutics, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-09$2.76/sh+19,000$52,440→ 912,114 total
Footnotes (1)
- [F1]Reflects the weighted average purchase price for shares of common stock purchased. Actual purchase prices for the shares purchased ranged from $2.675 to $2.85. The Reporting Person undertakes to provide TransCode Therapeutics, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.